![]() | ![]() |
Formats:
|
||||||||||||||||||
Copyright © 2008, Cold Spring Harbor Laboratory Press The anaphase-promoting complex/cyclosome (APC/C) is required for rereplication control in endoreplication cycles 1 University of Cologne, Institute for Genetics, 50674 Köln, Germany; 2 University of Zürich, Institute of Zoology, CH-8057 Zürich, Switzerland 3Present address: Fred Hutchinson Cancer Research Center, 1100 Fairview Ave. North, P.O. Box 19024, Seattle, Washington 98109, USA. 4Corresponding author.E-MAIL frank.sprenger/at/zool.uzh.ch; FAX 41-0-44-6356820. Received December 21, 2007; Accepted April 8, 2008. This article has been cited by other articles in PMC.Abstract Endoreplicating cells undergo multiple rounds of DNA replication leading to polyploidy or polyteny. Oscillation of Cyclin E (CycE)-dependent kinase activity is the main driving force in Drosophila endocycles. High levels of CycE–Cdk2 activity trigger S phase, while down-regulation of CycE-Cdk2 activity is crucial to allow licensing of replication origins. In mitotic cells relicensing in S phase is prevented by Geminin. Here we show that Geminin protein oscillates in endoreplicating salivary glands of Drosophila. Geminin levels are high in S phase, but drop once DNA replication has been completed. DNA licensing is coupled to mitosis through the action of the anaphase-promoting complex/cyclosome (APC/C). We demonstrate that, even though endoreplicating cells never enter mitosis, APC/C activity is required in endoreplicating cells to mediate Geminin oscillation. Down-regulation of APC/C activity results in stabilization of Geminin protein and blocks endocycle progression. Geminin is only abundant in cells with high CycE–Cdk2 activity, suggesting that APC/C–Fzr activity is periodically inhibited by CycE–Cdk2, to prevent relicensing in S-phase cells. Keywords: Anaphase-promoting complex, cell cycle, DNA licensing, Drosophila, endoreplication The precise duplication of the genome is crucial for the survival of any organism. In multicellular organisms genome instability potentially gives rise to cancer and thus compromises the life of the whole organism. To maintain the integrity of the genome, DNA replication, and mitosis must be coordinated during cell division cycles so that DNA replication occurs only once per cycle and mitosis only after complete duplication of the genome. To avoid rereplication events, a network of proteins ensures that cells acquire the license for DNA replication only in a specific phase of the cell cycle. DNA licensing involves the formation of prereplication complexes (pre-RC), which can only assemble during late mitosis and G1 (for review, see Bell and Dutta 2002; Blow and Dutta 2005). Pre-RC assembly on replication origins involves a variety of conserved components including the ORC1–6 complex, Cdc6, Cdt1/Double-parked, and the MCM2–7 helicase. Once MCM2–7 proteins are loaded onto the DNA, licensing is completed and the replication origins are ready for firing (for review, see Bell and Dutta 2002; Blow and Dutta 2005). Several mechanisms ensure that replication origins are fired only once during a cell cycle (for review, see Machida et al. 2005). Of particular importance is the temporal separation of pre-RC formation and origin firing. Pre-RC assembly occurs only in G1 because it depends on low Cdk activity while high Cdk activity is required for origin firing. The increase in Cdk activity at the G1–S transition does not only trigger origin firing, but at the same time also results in phosphorylation of several pre-RC components (ORC, Cdc6, Cdt1, and MCM2–7). These modifications are thought to prevent reassembly of these components into pre-RCs. Moreover, ongoing DNA replication results in Cdt1 instability mediated by a Cul4-dependent pathway (for review, see Arias and Walter 2007). In addition, pre-RC formation in S phase is blocked by Geminin, a protein that binds to Cdt1 and thereby inhibits loading of MCM2–7 proteins onto the chromatin (Wohlschlegel et al. 2000; Tada et al. 2001). Geminin accumulates during S, G2, and M phase but is destabilized during G1 by the action of an ubiquitin ligase, the anaphase-promoting complex/cyclosome (APC/C) (McGarry and Kirschner 1998). The APC/C has originally been identified because of its important role during mitosis (for review, see Peters 2006; Pines 2006). However, APC/C activity is also observed during G1 where it is crucial for the control of pre-RC formation, because it mediates the proteasomal degradation of Geminin and A/B-type cyclins. The APC/C-mediated proteasomal degradation of Geminin results in the release of Cdt1, and cyclin degradation creates a window of low Cdk1 activity, thereby allowing pre-RC formation. Recently this has been corroborated by analyzing cells in which Emi1, a negative regulator of APC/C activity, has been depleted. In these cells the APC/C is continuously activated, causing degradation of Geminin and A/B-type cyclins, which results in uncoordinated overreplication of the DNA (Di Fiore and Pines 2007; Machida and Dutta 2007). Analysis of imaginal disc cells depleted of Rca1, the Drosophila ortholog of Emi1 (Grosskortenhaus and Sprenger 2002), revealed that this mechanism of rereplication control also applies to flies (Supplemental Material). While rereplication without an intervening mitosis is strictly prevented during cell division cycles, this process is enforced during endoreplication cycles. This cell cycle variant is prominently found during plant and invertebrate development, but some mammalian cell types, like megakaryocytes or trophoblast giant cells, are also known to undergo endoreplication cycles (for review, see Edgar and Orr-Weaver 2001; Lilly and Duronio 2005). Endoreplicating cells undergo repeated rounds of DNA synthesis that are separated by distinct Gap phases (from here referred to as G phase), but never enter mitosis. In the last decade several studies have demonstrated that the proteins required for entry and progression through S phase during mitotic cycles are also essential for DNA replication during endoreplication cycles (for review, see Edgar and Orr-Weaver 2001; Lilly and Duronio 2005). However, it is still poorly understood how DNA licensing is regulated during endoreplication cycles. Drosophila Cyclin E (CycE) and its designated kinase partner Cdk2 are required for S phase during both mitotic and endoreplication cycles (Knoblich et al. 1994; Lane et al. 2000). Several studies have demonstrated that CycE levels oscillate in endoreplicating tissues (Lilly and Spradling 1996; de Nooij et al. 2000; Weng et al. 2003). The periodicity of CycE–Cdk2 activity appears to be essential for endoreplication, since continuous CycE expression prevents DNA replication in endocycling cells (Follette et al. 1998; Weiss et al. 1998), although the affected downstream targets have never been identified. Another regulator that has been implicated in the control of endoreplication is Fizzy-related (Fzr), the Drosophila ortholog of the APC/C activator Cdh1. Analysis of fzr mutants revealed that APC/C–Fzr activity is crucial for the transition from mitotic to endoreplication cycles (Sigrist and Lehner 1997; Schaeffer et al. 2004). At this step, APC/C activity is required to down-regulate A/B-type cyclins to prevent another round of mitotic proliferation. However, since expression of the main Fzr targets, the A/B-type cyclins, has not been reported in endoreplicating tissues, it has been suggested that APC/C–Fzr activity might only be required for the transition from mitotic to endoreplication cycles (Edgar and Orr-Weaver 2001; Lilly and Duronio 2005). The requirement of Fzr during endoreplication cycles has never been tested experimentally. Furthermore, it has not been addressed whether Geminin is involved in endoreplication. As Geminin-independent rereplication control is entirely sufficient during mitotic cycles in budding yeast, which does not have a Geminin ortholog (McGarry and Kirschner 1998), it was widely assumed that rereplication control during Drosophila endoreplication cycles relies on a mechanism resembling those in yeast (for review, see Bell and Dutta 2002). However, here we show that the APC/C–Fzr complex mediates the fluctuation of Geminin protein in endoreplicating salivary glands and demonstrate that APC/C–Fzr activity is required for normal endoreplication. Results rca1 is not required for rereplication control in endoreplicating cells In Drosophila, a variety of tissues is comprised of polyploid or polytene cells. These cells undergo endoreplication cycles, a cell cycle variant that is characterized by periodic DNA replication and the lack of M phases. The involvement of the APC/C inhibitor proteins, Emi1 and Rca1, in rereplication control during mitotic cycles (Supplemental Material; Di Fiore and Pines 2007; Machida and Dutta 2007) raised the question whether Rca1 activity is also required during endocycles. Therefore, we generated rca1 mutant cell clones in salivary glands that endoreplicate extensively during the larval stages. The rca1 mutant clones were induced by mitotic recombination using the MARCM technique (Lee and Luo 1999). Since mitotic recombination only occurs in proliferating cells, clones were already induced during embryogenesis when the salivary gland precursor cells still divide mitotically. Inspection of DNA contents at the third instar stage revealed that the DNA staining in rca1 mutant cells (marked by GFP) is indistinguishable from those of the surrounding control cells. This indicates that rca1 is not essential for progression through endoreplication cycles. Expression of mitotic genes and Fzr in endoreplicating cells Our finding that Rca1 is not required during endocycles suggested that the APC/C, whose activity needs to be restricted by Rca1 during mitotic cycles, might not have a role during endoreplication cycles either. After initiation of the first G1 phase during embryogenesis, virtually all cells of internal organs undergo endoreplication (Smith and Orr-Weaver 1991). Previous studies have clearly established that APC/C–Fzr activity is required for the transition form mitotic to endocycles during embryogenesis (Sigrist and Lehner 1997), but a later requirement of APC/C activity during progression through endoreplication cycles has not yet been addressed. Moreover, because a variety of proteins targeted for proteasomal degradation by the APC/C during mitotic cycles are transcriptionally down-regulated in endoreplicating cells (Klebes et al. 2002), the APC/C has often been assumed to be dispensable during endoreplication cycles. To determine the role of APC/C during endoreplication cycles, we started a careful comparison of transcript levels of selected genes encoding APC/C subunits including Fzr, as well as some cell cycle regulators during mitotic and endoreplication cycles. RNA derived from embryos (4–8 h after egg deposition [AED]) where cells proliferate mitotically and endoreplicating salivary glands from feeding larvae were analyzed by quantitative RT–PCR (qRT–PCR). This approach revealed that transcript levels of the tested cell cycle genes were generally reduced in salivary glands, but the degree of reduction varied considerably (Fig. 1B
Overexpression of HA-Rca1 impairs endocycle progression The finding that APC/C–Fzr is present at significant levels in larval salivary glands suggested that APC/C activity might be required during endocycles. To address this possibility we ectopically expressed the APC/C–Fzr inhibitor Rca1 (Grosskortenhaus and Sprenger 2002) at different time points after the initiation of endoreplication. For conditional expression of UAS-HA-Rca1 we used ptc-Gal4, which is active in salivary glands (Pierce et al. 2004), in combination with a temperature-sensitive variant of the Gal4 inhibitor Gal80 (McGuire et al. 2004). When larvae were cultured at 18°C (permissive temperature for Gal80ts), salivary glands did not display HA-Rca1 staining (Fig. 2A
Depletion of APC/C activity compromises endoreplication To corroborate our finding that HA-Rca1 overexpression, impairs endocycle progression in larval salivary glands we performed BrdU labeling. Larvae were fed with BrdU for 24 h and antibody staining was used for visualization of incorporated BrdU in salivary glands. All nuclei of wild-type salivary glands showed BrdU staining (Fig. 3A
To verify that suppression of APC/C activity impairs endoreplication, we depleted Cdc16, a core component of the APC/C (Huang and Raff 2002; Pal et al. 2007). Overexpression of an RNAi construct targeting Cdc16 in imaginal disc cells resulted in a mitotic arrest phenotype (Supplemental Fig. S2), as expected from a knockdown of APC/C function (Deak et al. 2003; Pal et al. 2007). Expression of the Cdc16-specific UAS-RNAi construct in salivary glands, using ptc-Gal4 in combination with Gal80ts, was induced at 10–18 h AED to deplete APC/C function after the onset of endoreplication. The resulting salivary glands displayed a reduced size (Fig. 4D
APC/C-depleted cells exhibit hallmarks of increased CycE–Cdk2 activity The similarity between the Rca1 and CycE overexpression phenotypes prompted us to test whether inactivation of the APC/C–Fzr complex results in persistently high CycE–Cdk2 activity. In Drosophila, the monoclonal MPM-2 antibody is widely used to monitor CycE–Cdk2 activity (Calvi et al. 1998; Royzman et al. 1999). The MPM-2 antibody recognizes a Cdk2-regulated protein that assembles into the histone locus body (White et al. 2007). The presence of MPM-2-positive nuclear spheres correlates with CycE–Cdk2 activity. In wild-type salivary glands dissected from wandering third instar larvae that had finished endoreplication and were thus supposed to have low CycE–Cdk2 activity, we did not detect these MPM-2-positive nuclear spheres, as expected (Fig. 4A APC/C inactivation increases CycE level through E2F1 stabilization CycE–Cdk2 activity appears to be elevated in APC/C-depleted salivary glands, raising the question whether Rca1 misexpression affects CycE levels. We used the flp-out method to create salivary glands overexpressing Rca1 in individual cells. These mosaic salivary glands contained cells with varying overexpression levels, presumably because of a variable efficiency of removal of the multiple flp-out cassettes from the polytene chromosomes (Fig. 5A
In mitotic cells CycE and the transcription factor E2F1/Dp cooperate in an autoregulatory feedback loop that ensures accumulation of CycE prior to S-phase entry (Duronio and O’Farrell 1995; Sauer et al. 1995). To determine whether this feedback loop operates in endoreplicating cells, we overexpressed CycE in salivary glands using the flp-out method. This also resulted in up-regulation of the CycE-lacZ reporter construct (Fig. 5C To test if this autoregulatory feedback loop relies on the transcription factor E2F1/Dp, we performed qRT–PCR on RNA derived from salivary glands in which CycE or HA-Rca1 was overexpressed and compared transcript levels with those from wild-type salivary glands (Fig. 5D Geminin is a critical APC/C target in endoreplicating cells Our findings demonstrate that inhibition of APC/C activity results in higher E2F1 and CycE levels and interferes with endoreplication. The APC/C controls the abundance of a plethora of proteins, raising the question: Which APC/C target might cause the block of endoreplication? Geminin appeared as a highly attractive candidate because it is involved in the regulation of pre-RC formation during mitotic cycles (McGarry and Kirschner 1998). Immunostaining revealed that Geminin levels were highly elevated in HA-Rca1-overexpressing cells (Fig. 6A
In wild-type salivary glands dissected from feeding larvae, Geminin is only detectable in a subset of cells (Fig. 6C–E Discussion In this study we show that APC/C–Fzr activity is essential for endocycle progression. Our data suggests that the APC/C–Fzr complex regulates the abundance of the Geminin protein during salivary gland endoreplication cycles, and that this is important to prevent relicensing in S phase. Inactivation of the APC/C–Fzr complex in larval salivary glands is accompanied by impaired DNA replication and stabilization of Geminin protein. Consistent with this observation recent work demonstrated that giant trophoblast cells in Fzr knockout mice fail to undergo endoreplication (I. Garcia-Higuera, M. Malumbres, and S. Moreno, pers. comm.). Our findings about the requirement of the APC/C during endoreplication cycles are consistent with previous studies on mr/APC2 mutants that display small salivary glands with thin polytene chromosomes (Reed and Orr-Weaver 1997). Furthermore, our results are in agreement with a recent publication that independently demonstrates that depletion of APC/C activity compromises endoreplication in larval salivary glands (Narbonne-Reveau et al. 2008). It has been proposed that the endocycle is driven by oscillating activities of the transcription factor E2F1 and CycE, which acts in concert with its designated kinase partner Cdk2 (Edgar and Nijhout 2004). In agreement with the model suggested by Edgar and Nijhout, we found that E2F1 and CycE levels fluctuate in endoreplicating in salivary glands. Moreover, double-labeling experiments with BrdU have revealed that E2F1 is only abundant in cells that reside in G phase, but absent in cells with ongoing DNA replication (V.K. Tran and B.A. Edgar, pers. comm.). CycE displays a complementary pattern since it accumulates in late G phase and persists throughout S phase (Weng et al. 2003). These observations are consistent with a model in which E2F1 and its cofactor dDP activate the transcription of CycE during late G1 phase. CycE–Cdk2 then enhances its own activity by inhibiting the E2F1 repressor Rbf (Du et al. 1996) resulting in a sharp peak of Cdk2 activity, which eventually triggers S-phase entry. The onset of DNA replication in turn initiates a negative feedback loop that down-regulates E2F1 activity and simultaneously triggers dup/Cdt1 degradation (May et al. 2005). The short half-live of CycE mRNA and protein would then suffice to cause a drop in CycE–Cdk2 activity after completion of DNA replication (Fig. 7
CycE–Cdk2 regulates APC/C–Fzr activity in salivary glands Three pathways tightly control APC/C–Fzr activity during the mitotic cycles of Drosophila embryogenesis. The best characterized inhibitor of the APC/C–Fzr complex is Rca1, the Drosophila ortholog of the vertebrate Emi1 proteins (Grosskortenhaus and Sprenger 2002). In addition, it has been demonstrated that CycA–Cdk1 and CycE–Cdk2 complexes also contribute to APC/C–Fzr inhibition during Drosophila embryogenesis (Sigrist and Lehner 1997; Grosskortenhaus and Sprenger 2002; Dienemann and Sprenger 2004; Reber et al. 2006). However, expression profiling showed that CycA, Cdk1, and Rca1 are only weakly expressed in larval salivary glands, indicating that these genes are presumably not involved in APC/C–Fzr regulation during endoreplication. Moreover, we found no obvious phenotype in salivary gland cells mutant for rca1. The result that Rca1 activity is required in mitotic but not in endoreplicating cells is consistent with the phenotype of Emi1-deficient mice, in which the mitotic cells of the inner cell mass cells die, whereas the endoreplicating trophoblast giant cells appear normal (Lee et al. 2006). Therefore, CycE–Cdk2 is the only known APC/C–Fzr inhibitor in larval salivary glands. Double-labeling experiments on endoreplicating salivary glands revealed that Geminin is only abundant in cells with high CycE–Cdk2 activity. Furthermore, we found that Geminin protein accumulates in salivary gland cells that continuously overexpress CycE from a transgene. The idea that the APC/C–Fzr complex is negatively regulated by CycE-dependent kinase activity has recently been corroborated by biochemical data, which showed that human CycE–Cdk2 can phosphorylate Cdh1/Fzr and thereby promote its dissociation from the APC/C core complex (Keck et al. 2007). The unique function of Cyclin E during endoreplication is emphasized by the finding that trophoblast giant cells and megakaryocytes in Cyclin E-deficient mice fail to undergo endoreplication, whereas mitotic cells proliferate rather normally (Geng et al. 2003; Parisi et al. 2003). These observations have substantial implications for the current view of endoreplication. We propose that CycE/Cdk2-mediated inhibition of APC/C activity ensures that the peak of CycE-dependent kinase activity simultaneously initiates DNA replication, and prevents relicensing through stabilization of Geminin. In the following G phase, when CycE–Cdk2 activity is low, the APC/C–Fzr complex is released from this inhibition and targets Geminin for proteasomal degradation, allowing licensing of replication origins (Fig. 7 Geminin is important to prevent rereplication in endocycle S phases In the endoreplicating tissues of geminin mutant embryos massive overreplication has been observed, demonstrating that Geminin activity is required to limit DNA replication during endoreplication (Quinn et al. 2001). Conversely, we found that endoreplication is severely impaired in salivary gland cells forced to overexpress Geminin. This suggests that the impaired endoreplication observed in cells overexpressing either Rca1 or CycE results from elevated Geminin levels. However, it cannot be excluded that other APC/C-regulated proteins, besides Geminin, contribute to the endocycle arrest observed upon APC/C inactivation. A recent study on Geminin-deficient mice revealed that cells lacking Geminin have higher DNA contents than wild-type cells and therefore the investigators suggested that loss of Geminin commits mitotic cells to endoreplication (Gonzalez et al. 2006). This hypothesis contradicts our model in which Geminin is essential for rereplication control during endoreplication. However, no flow cytometric analysis was included in this study to confirm that Geminin mutant mouse cells underwent true endocycles with distinct G phases, rather than overreplicating their DNA continuously due to the lack of proper licencing control. Consistent with our finding that Geminin accumulates upon inactivation of the APC/C–Fzr complex, Gonzalez et al. reported that treatment of mouse embryos with a proteasome inhibitor led to the stabilization of Geminin protein. The investigators of this study claimed that the APC/C–Fzr complex is constitutively activated in endoreplicating cells, and that constant degradation of Geminin is part of the normal mechanism of endocycle regulation. However, we could demonstrate that Geminin is present in endoreplicating cells of the salivary gland. In agreement with its established function to control DNA licencing, we found that Geminin is present during S phase but absence in G phase. These oscillations are likely caused by periodic inhibition of APC/C–Fzr activity by CycE–Cdk2. Thus, we propose that the fluctuation of Geminin protein is crucial for the control DNA licensing during endoreplication. Futhermore, we suggest that similar oscillations of APC/C activity and Geminin levels also occur in endoreplicating cells of mouse embryos. Materials and methods Fly stocks w1118 flies were used as a control and further on referred to as wild type. Strains carrying UAS-RNAi constructs were obtained from the RNAi collection at the National Institute for Genetics (Mishima, Shizuoka, Japan): UAS-Cdc16-RNAi (6759R-3) and UAS-Rca1-RNAi (10800R-1, 10800R-2). Mutant or transgene fly stocks that were described elsewhere: w; Frt40A, rca12/ CyOwg-lacZ,and UAS-HA-Rca1 (Grosskortenhaus and Sprenger 2002); UAS-CycE (Sigrist and Lehner 1997); UAS-Geminin (Quinn et al. 2001); CycE-lacZ16,4kb (Jones et al. 2000; Wu et al. 2003); PCNA-GFP (Thacker et al. 2003); en-Gal4; UAS-GFP/SM6-TM6 (Neufeld et al. 1998); hh-Gal4 (Tanimoto et al. 2000); GFP-Cdc16 (Huang and Raff 2002). Stocks used for clonal analysis and conditional expression of UAS constructs were kindly provided by Thomas Klein (University of Cologne, Germany): w, hs-flp1.22; act < y+ > Gal4(25), UAS-GFP/SM6-TM6; w, hs-flp1.22, tub-Gal4, UAS-GFP/FM7; Frt40A, Gal80/CyO, and w; ptc-Gal4, UAS-GFP; tub-Gal80ts/TM6B Fly breeding Wild-type larvae were collected on grape juice plates and staged to 72–74 h AED at 25°C. The TARGET system and ptc-Gal4 was used for conditional overexpression of UAS constructs in salivary glands (McGuire et al. 2004; Pierce et al. 2004). Embryos were collected for 18 h at 18°C and aged then for another 22 h/88 h at 18°C. Expression in salivary glands was induced by shifting temperature to 29°C. Samples were raised at 29°C until larvae initiated wandering, and were then immediately used for immunohistochemistry. Drosophila development is accelerated by cultivation at 29°C, whereas it is retarded at 18°C. Therefore, all incubation times were normalized to developmental timing at 25°C according to Buttitta et al. (2007). Individual salivary gland cells overexpressing certain UAS constructs were generated by the flp-out technique (Ito et al. 1997). Expression was induced 40–48 h by a 10-min heat shock at 37°C. Loss of function clones in the salivary placode were created with the MARCM technique (Lee and Luo 1999). Embryos were collected for 8 h at 25°C and subsequently heat-shocked for 1 h at 37°C. Both MARCM and flp-out experiments were cultivated at 25°C until larvae initiated wandering and subsequently analyzed by immunohistochemistry. To determine depletion efficiencies, UAS–RNAi constructs were continuously overexpressed in wing imaginal discs using either en-Gal4 or hh-Gal4. In this case, flies were cultivated at 29°C to achieve maximum expression strength with the UAS/Gal4 system. Detailed information about temporal parameters of the experiments can be found in the Supplemental Material. Immunohistochemistry Salivary glands were dissected in PBS and fixed for 30 min at 24°C in 4% paraformaldehyde/PBS. Isolated tissues were blocked for 1 h at 24°C in PBS/0.3% Triton X-100/5% NGS. Primary antibodies were used in the following dilutions: rat anti-HA (1:100; Roche), rat anti-Geminin (1:500) (Quinn et al. 2001), guinea pig anti-CycE (1:500 to 1:800; gift of T. Orr-Weaver, Whitehead Institute, Cambridge, MA), guinea pig anti-E2F1 (1:500, T. Orr-Weaver); rabbit anti-GFP (1:500; Torrey Pines Biolabs); mouse anti-MPM-2 (1:200; Millipore), and mouse anti-BrdU (1:20; Becton Dickinson). Secondary antibodies, purchased from Invitrogen, were used at a dilution of 1:500. DNA was visualized with Hoechst 33258 (0.5 mg/mL; Sigma) diluted 1:2000. For BrdU labeling, 200 μg/mL BrdU (Sigma) in 20% sucrose/PBS was added to the medium 60 h after induction of genes expression. After 20 h of incubation at 29°C, salivary glands were isolated and processed according to Baker and Yu (2001). Samples were generally mounted in Vectashield (Vector Laboratories). Image acquisition and processing Epifluorescence images of whole salivary glands were taken on a Zeiss AxioImager fitted with a CCD camera (Zeiss AxioCam MRc5). Higher resolution images represent single confocal sections that were acquired either on a Zeiss AxioImager fluorescent microscope equipped with an Apotome slider module (Zeiss) or on a Leica TCS-SP2 laser scanning microscope. High-resolution images of salivary gland nuclei shown in Figure 5 Quantitative real-time PCR Detailed information about the qRT–PCR analysis can be found in the Supplemental Material. Western blotting Extracts containing different amounts of wild-type embryos or larval salivary glands were separated by SPS-PAGE and transferred to nitrocellulose membranes according to standard methods. Blotted membranes were stained with Ponceau S and then probed with following primary antibodies: rabbit anti-Fzr (1:20) (Jacobs et al. 2002); mouse anti-tubulin (1:3000; Sigma). Appropriate HRP-coupled secondary antibodies purchased from Jackson Immunolabs were diluted 1:1000. Proteins were visualized using the ECL-Western blotting detection system (Amersham). Acknowledgments N.Z. is grateful to Bruce A. Edgar for communication of unpublished results and the allowance to complete this work in his laboratory. We also acknowledge T. Orr-Weaver, H. Richardson, M. Asano, R. Duronio, T. Klein, and the National Institute of Genetics (Japan) for providing reagents, as well as M. Zigman for critical reading of the manuscript. Finally, we thank S. Moreno for the permission to discuss data prior to publication. This work was partly funded by a post-doctoral fellowship from the German Academic Exchange Service (DAAD) to N.Z., NIH grant GM51186 to B.A.E., and by the Deutsche Forschungsgemeinschaft through SFB grant 572 to F.S. Footnotes Supplemental material is available at http://www.genesdev.org. Article is online at http://www.genesdev.org/cgi/doi/10.1101/gad.469108. References
|
PubMed related articles
Your browsing activity is empty. Activity recording is turned off. |
|||||||||||||||||
Annu Rev Biochem. 2002; 71():333-74.
[Annu Rev Biochem. 2002]Nat Rev Mol Cell Biol. 2005 Jun; 6(6):476-86.
[Nat Rev Mol Cell Biol. 2005]Cell. 2005 Oct 7; 123(1):13-24.
[Cell. 2005]Genes Dev. 2007 Mar 1; 21(5):497-518.
[Genes Dev. 2007]Science. 2000 Dec 22; 290(5500):2309-12.
[Science. 2000]Nat Cell Biol. 2001 Feb; 3(2):107-13.
[Nat Cell Biol. 2001]Cell. 1998 Jun 12; 93(6):1043-53.
[Cell. 1998]Cell. 2001 May 4; 105(3):297-306.
[Cell. 2001]Oncogene. 2005 Apr 18; 24(17):2765-75.
[Oncogene. 2005]Cell. 1994 Apr 8; 77(1):107-20.
[Cell. 1994]Genetics. 2000 May; 155(1):233-44.
[Genetics. 2000]Genes Dev. 1996 Oct 1; 10(19):2514-26.
[Genes Dev. 1996]Cell. 1997 Aug 22; 90(4):671-81.
[Cell. 1997]Curr Biol. 2004 Apr 6; 14(7):630-6.
[Curr Biol. 2004]Cell. 2001 May 4; 105(3):297-306.
[Cell. 2001]Oncogene. 2005 Apr 18; 24(17):2765-75.
[Oncogene. 2005]Cell. 1998 Jun 12; 93(6):1043-53.
[Cell. 1998]J Cell Biol. 2007 May 7; 177(3):425-37.
[J Cell Biol. 2007]Genes Dev. 2007 Jan 15; 21(2):184-94.
[Genes Dev. 2007]Neuron. 1999 Mar; 22(3):451-61.
[Neuron. 1999]Development. 1991 Aug; 112(4):997-1008.
[Development. 1991]Cell. 1997 Aug 22; 90(4):671-81.
[Cell. 1997]Genome Biol. 2002 Jul 24; 3(8):RESEARCH0038.
[Genome Biol. 2002]Development. 1997 Sep; 124(18):3543-53.
[Development. 1997]Proc Natl Acad Sci U S A. 2002 Aug 20; 99(17):11217-22.
[Proc Natl Acad Sci U S A. 2002]Dev Cell. 2002 Jan; 2(1):29-40.
[Dev Cell. 2002]Development. 2004 May; 131(10):2317-27.
[Development. 2004]Sci STKE. 2004 Feb 12; 2004(220):pl6.
[Sci STKE. 2004]Cell. 1997 Aug 22; 90(4):671-81.
[Cell. 1997]Development. 1997 Feb; 124(4):761-71.
[Development. 1997]Curr Biol. 1998 Feb 12; 8(4):235-8.
[Curr Biol. 1998]Curr Biol. 1998 Feb 12; 8(4):239-42.
[Curr Biol. 1998]J Cell Sci. 2002 Jul 15; 115(Pt 14):2847-56.
[J Cell Sci. 2002]J Cell Sci. 2007 Sep 15; 120(Pt 18):3238-48.
[J Cell Sci. 2007]J Cell Sci. 2003 Oct 15; 116(Pt 20):4147-58.
[J Cell Sci. 2003]Genes Dev. 1998 Mar 1; 12(5):734-44.
[Genes Dev. 1998]Genes Dev. 1999 Apr 1; 13(7):827-40.
[Genes Dev. 1999]Mol Biol Cell. 2007 Jul; 18(7):2491-502.
[Mol Biol Cell. 2007]Development. 2000 Nov; 127(21):4619-30.
[Development. 2000]Genes Dev. 1995 Jun 15; 9(12):1456-68.
[Genes Dev. 1995]Genes Dev. 1995 Jun 1; 9(11):1327-39.
[Genes Dev. 1995]Genes Dev. 1995 Jun 15; 9(12):1456-68.
[Genes Dev. 1995]Curr Biol. 2003 Jan 8; 13(1):53-8.
[Curr Biol. 2003]Genes Dev. 1996 Jun 1; 10(11):1422-32.
[Genes Dev. 1996]BMC Genet. 2003 Jun 4; 4():9.
[BMC Genet. 2003]Cell. 2004 Apr 16; 117(2):253-64.
[Cell. 2004]Cell. 1998 Jun 12; 93(6):1043-53.
[Cell. 1998]Cell. 1997 Aug 22; 90(4):671-81.
[Cell. 1997]Dev Cell. 2002 Jan; 2(1):29-40.
[Dev Cell. 2002]Development. 2006 Aug; 133(16):3201-11.
[Development. 2006]J Cell Biol. 2007 Jul 30; 178(3):371-85.
[J Cell Biol. 2007]EMBO J. 2003 Aug 1; 22(15):3865-75.
[EMBO J. 2003]Genes Dev. 1995 Jun 15; 9(12):1456-68.
[Genes Dev. 1995]Curr Biol. 2003 Jan 8; 13(1):53-8.
[Curr Biol. 2003]Cell. 1998 Jun 12; 93(6):1043-53.
[Cell. 1998]Development. 1997 Sep; 124(18):3543-53.
[Development. 1997]Development. 2008 Apr; 135(8):1451-61.
[Development. 2008]EMBO J. 2003 Aug 1; 22(15):3865-75.
[EMBO J. 2003]Genes Dev. 1996 May 15; 10(10):1206-18.
[Genes Dev. 1996]J Cell Sci. 2005 Sep 15; 118(Pt 18):4207-17.
[J Cell Sci. 2005]Dev Cell. 2002 Jan; 2(1):29-40.
[Dev Cell. 2002]Cell. 1997 Aug 22; 90(4):671-81.
[Cell. 1997]Curr Biol. 2004 Jun 22; 14(12):1117-23.
[Curr Biol. 2004]Development. 2006 Aug; 133(16):3201-11.
[Development. 2006]Mol Cell Biol. 2006 Jul; 26(14):5373-81.
[Mol Cell Biol. 2006]Genes Dev. 2001 Oct 15; 15(20):2741-54.
[Genes Dev. 2001]Genes Dev. 2006 Jul 15; 20(14):1880-4.
[Genes Dev. 2006]Dev Cell. 2002 Jan; 2(1):29-40.
[Dev Cell. 2002]Cell. 1997 Aug 22; 90(4):671-81.
[Cell. 1997]Genes Dev. 2001 Oct 15; 15(20):2741-54.
[Genes Dev. 2001]Development. 2000 Nov; 127(21):4619-30.
[Development. 2000]Cell. 2003 Aug 22; 114(4):445-56.
[Cell. 2003]Sci STKE. 2004 Feb 12; 2004(220):pl6.
[Sci STKE. 2004]Development. 2004 May; 131(10):2317-27.
[Development. 2004]Dev Cell. 2007 Apr; 12(4):631-43.
[Dev Cell. 2007]Development. 1997 Feb; 124(4):761-71.
[Development. 1997]Neuron. 1999 Mar; 22(3):451-61.
[Neuron. 1999]Genes Dev. 2001 Oct 15; 15(20):2741-54.
[Genes Dev. 2001]Cell. 2001 Mar 9; 104(5):699-708.
[Cell. 2001]Curr Biol. 2002 Aug 20; 12(16):1435-41.
[Curr Biol. 2002]